BACKGROUND Bifidobacterium pseudolongum is widely exists in mammal gut and its
abundance is associated with human and animal health. The present study aimed to …

Bifidobacterium longum is frequently utilized and has broad prospects for preventing liver
injury. The current research assessed the antioxidant capacity of B. longum BL-10 and …

Acute liver failure is a drastic, unpredictable clinical syndrome with high mortality. Various
preventive and adjuvant therapies based on modulating the gut flora have been proposed …

Intestinal ischemia–reperfusion (IIR) injury leads to inflammation and oxidative stress,
resulting in intestinal barrier damage. Probiotics, due to their anti-inflammatory and …

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease with many
influencing factors. With the increasing role of the gut–liver axis in various liver diseases …

The gut microbiota is altered in liver diseases, and several probiotics have been shown to
reduce the degree of liver damage. We hypothesized that oral administration of specific …

Objective To investigate the effect of Bifidobacterium animalis B94 on the prevention and
treatment of liver injury in rats and to elucidate the underlying mechanism of this …

There has been a rising interest in studying how Bifidobacterium breve can affect the
immune system over the years. The aim of this study was to evaluate the effect of B. breve on …

In recent years, acute liver injury (ALI) has received wide-range attention in the world due to
its relatively high morbidity and mortality. This study aimed to explore the hepatoprotective …

Acute liver failure is a severe liver disorder that poses considerable global challenges.
Previous studies on Bifidobacterium longum R0175 have mainly focused on its psychotropic …